Combined use of calcium phosphate cement, mesenchymal stem cells and platelet-rich plasma for bone regeneration in critical-size defect of the femoral condyle in mini-pigs

References

• 1. Obremskey WT, Molina CS, Collinge C et al. Current practice in the management of segmental bone defects among orthopaedic trauma surgeons. J. Orthop. Trauma 28(8), e203–e207 (2013).
  Google Scholar
• 2. Pannier S. Congenital pseudarthrosis of the tibia. Orthop. Traumatol. Surg. Res. 97(7), 750–761 (2011).
  Medline CASGoogle Scholar
• 3. Kinkel S, Lehner B, Kleinhans JA et al. Medium to long-term results after reconstruction of bone defects at the knee with tumor endoprostheses. J. Surg. Oncol. 101(2), 166–169 (2010).
  Medline CASGoogle Scholar
• 4. Calori GM, Mazza E, Colombo M et al. The use of bone-graft substitutes in large bone defects: any specific needs? Injury 42(S2), S56–S63 (2011).
  MedlineGoogle Scholar
• 5. Dimitriou R, Mataliotakis GI, Angoules AG et al. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury 42(S2), S3–S15 (2011).
  MedlineGoogle Scholar
• 6. Loeffler BJ, Kellam JF, Sims SH et al. Prospective observational study of donor-site morbidity following anterior iliac crest bone-grafting in orthopaedic trauma reconstruction patients. J. Bone Joint Surg. Am. 94(18), 1649–1654 (2012).
  MedlineGoogle Scholar
• 7. Campana V, Milano G, Pagano E et al. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J. Mater. Sci. Mater. Med. 25(10), 2445–2461 (2014).
  Medline CASGoogle Scholar
• 8. Wang W, Yeung WK. Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioact. Mater. 2(4), 224–247 (2017).
  MedlineGoogle Scholar
• 9. Schemitsch EH. Size matters: defining critical in bone defect size! J. Orthop. Trauma 31(S5), S20–S22 (2017).
  MedlineGoogle Scholar
• 10. Hollinger JO, Kleinschmidt JC. The critical size defect as an experimental model to test bone repair materials. J. Craniofac. Surg. 1(1), 60–68 (1990).
  Medline CASGoogle Scholar
• 11. Chow LC. Calcium phosphate materials: reactor response. Adv. Dent. Res. 2(1), 181–184; discussion 185–186 (1988).
  Medline CASGoogle Scholar
• 12. Chow LC. Next generation calcium phosphate-based biomaterials. Dent. Mater. J. 28(1), 1–10 (2009).
  Medline CASGoogle Scholar
• 13. Zhao L, Burguera EF, Xu HH et al. Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosan-biodegradable fiber scaffolds. Biomaterials 31(5), 840–847 (2010).
  Medline CASGoogle Scholar
• 14. Ben-Ari A, Rivkin R, Frishman M et al. Isolation and implantation of bone marrow-derived mesenchymal stem cells with fibrin micro beads to repair a critical-size bone defect in mice. Tissue. Eng. Part A. 15(9), 2537–2546 (2009).
  Medline CASGoogle Scholar
• 15. Chen W, Liu J, Manuchehrabadi N et al. Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects. Biomaterials 34(38), 9917–9925 (2013).
  Medline CASGoogle Scholar
• 16. Gao C, Harvey EJ, Chua M et al. MSC-seeded dense collagen scaffolds with a bolus dose of VEGF promote healing of large bone defects. Eur. Cell. Mater. 26, 195–207; discussion 207 (2013).
  Medline CASGoogle Scholar
• 17. Niemeyer P, Fechner K, Milz S et al. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials 31(13), 3572–3579 (2010).
  Medline CASGoogle Scholar
• 18. Zeng D, Xia L, Zhang W et al. Maxillary sinus floor elevation using a tissue-engineered bone with calcium-magnesium phosphate cement and bone marrow stromal cells in rabbits. Tissue. Eng. Part A. 18(7-8), 870–881 (2012).
  Medline CASGoogle Scholar
• 19. Zhao L, Weir MD, Xu HH. Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials 31(14), 3848–3857 (2010).
  Medline CASGoogle Scholar
• 20. Marx RE, Carlson ER, Eichstaedt RM et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 85(6), 638–646 (1998).
  Medline CASGoogle Scholar
• 21. Hakimi M, Jungbluth P, Sager M et al. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. Injury 41(7), 717–723 (2010).
  Medline CASGoogle Scholar
• 22. Han B, Yang Z, Fang JY et al. The effects of heparin binding proteins in platelet releasate on bone formation. Tissue. Eng. Part A. 20(7-8), 1263–1270 (2014).
  Medline CASGoogle Scholar
• 23. Intini G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials 30(28), 4956–4966 (2009).
  Medline CASGoogle Scholar
• 24. Latalski M, Elbatrawy YA, Thabet AM et al. Enhancing bone healing during distraction osteogenesis with platelet-rich plasma. Injury 42(8), 821–824 (2011).
  MedlineGoogle Scholar
• 25. Nair MB, Varma HK, Menon KV et al. Reconstruction of goat femur segmental defects using triphasic ceramic-coated hydroxyapatite in combination with autologous cells and platelet-rich plasma. Acta. Biomater. 5(5), 1742–1755 (2009).
  Medline CASGoogle Scholar
• 26. Qiu G, Shi Z, Xu HK et al. Bone regeneration in mini-pigs via calcium phosphate cement scaffold delivering autologous bone marrow mesenchymal stem cells and platelet-rich plasma. J. Tissue. Eng. Regen. Med. 12(2), e937–e948 (2018).
  Medline CASGoogle Scholar
• 27. Schlegel F, Appler M, Halling M et al. Reprogramming bone marrow stem cells to functional endothelial cells in a mini pig animal model. Med. Sci. Monit. Basic. Res. 23, 285–294 (2017).
  MedlineGoogle Scholar
• 28. Birmingham E, Niebur GL, McHugh PE et al. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur. Cell. Mater. 23, 13–27 (2012).
  Medline CASGoogle Scholar
• 29. Futrega K, Mosaad E, Chambers K et al. Bone marrow-derived stem/stromal cells (BMSC) 3D microtissues cultured in BMP-2 supplemented osteogenic induction medium are prone to adipogenesis. Cell Tissue Res. 374(3), 541–553 (2018).
  Medline CASGoogle Scholar
• 30. Wang P, Zhao L, Chen W et al. Stem cells and calcium phosphate cement scaffolds for bone regeneration. J. Dent. Res. 93(7), 618–625 (2014).
  Medline CASGoogle Scholar
• 31. Jo CH, Roh YH, Kim JE et al. Optimizing platelet-rich plasma gel formation by varying time and gravitational forces during centrifugation. J. Oral. Implantol. 39(5), 525–532 (2013).
  MedlineGoogle Scholar
• 32. Kim L, Toh YC, Voldman J et al. A practical guide to microfluidic perfusion culture of adherent mammalian cells. Lab. Chip. 7(6), 681–694 (2007).
  Medline CASGoogle Scholar
• 33. Ahern BJ, Parvizi J, Boston R et al. Preclinical animal models in single site cartilage defect testing: a systematic review. Osteoarthr. Cartil. 17(6), 705–713 (2009).
  Medline CASGoogle Scholar
• 34. Cole BJ, Seroyer ST, Filardo G et al. Platelet-rich plasma: where are we now and where are we going? Sports Health 2(3), 203–210 (2010).
  MedlineGoogle Scholar
• 35. Xu HH, Zhao L, Weir MD. Stem cell-calcium phosphate constructs for bone engineering. J. Dent. Res. 89(12), 1482–1488 (2010).
  Medline CASGoogle Scholar
• 36. Wang SJ, Jiang D, Zhang ZZ et al. Chondrogenic potential of peripheral blood derived mesenchymal stem cells seeded on demineralized cancellous bone scaffolds. Sci. Rep. 6, 36400 (2016).
  Medline CASGoogle Scholar
• 37. Wahl EA, Fierro FA, Peavy TR et al. In vitro evaluation of scaffolds for the delivery of mesenchymal stem cells to wounds. Biomed. Res. Int. 2015, 108571 (2015).
  MedlineGoogle Scholar
• 38. Li DW, Lei X, He FL et al. Silk fibroin/chitosan scaffold with tunable properties and low inflammatory response assists the differentiation of bone marrow mesenchymal stem cells. Int. J. Biol. Macromol. 105(Pt1), 584–597 (2017).
  Medline CASGoogle Scholar
• 39. Li X, Zhang R, Tan X et al. Synthesis and evaluation of BMMSC-seeded BMP-6/nHAG/GMS scaffolds for bone regeneration. Int. J. Med. Sci. 16(7), 1007–1017 (2019).
  Medline CASGoogle Scholar
• 40. Friedenstein AJ, Petrakova KV, Kurolesova AI et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6(2), 230–247 (1968).
  Medline CASGoogle Scholar
• 41. Friedenstein AJ, Piatetzky S, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16(3), 381–390 (1966).
  Medline CASGoogle Scholar
• 42. Bielby R, Jones E, McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury. 38(S1), S26–S32 (2007).
  MedlineGoogle Scholar
• 43. Kagami H, Agata H, Tojo A. Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation. Int. J. Biochem. Cell Biol. 43(3), 286–289 (2011).
  Medline CASGoogle Scholar
• 44. Meijer GJ, de Bruijn JD, Koole R et al. Cell based bone tissue engineering in jaw defects. Biomaterials 29(21), 3053–3061 (2008).
  Medline CASGoogle Scholar
• 45. Agata H, Asahina I, Watanabe N et al. Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage. Tissue. Eng. Part A. 16(2), 663–673 (2010).
  Medline CASGoogle Scholar
• 46. Janicki P, Boeuf S, Steck E et al. Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Eur. Cell. Mater. 21, 488–507 (2011).
  Medline CASGoogle Scholar
• 47. Oliveira JM, Rodrigues MT, Silva SS et al. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: scaffold design and its performance when seeded with goat bone marrow stromal cells. Biomaterials 27(36), 6123–6137 (2006).
  Medline CASGoogle Scholar
• 48. Ye X, Yin X, Yang D et al. Ectopic bone regeneration by human bone marrow mononucleated cells, undifferentiated and osteogenically differentiated bone marrow mesenchymal stem cells in beta-tricalcium phosphate scaffolds. Tissue Eng. Part C. Methods 18(7), 545–556 (2012).
  Medline CASGoogle Scholar
• 49. Kasten P, Vogel J, Geiger F et al. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29(29), 3983–3992 (2008).
  Medline CASGoogle Scholar
• 50. Tavassoli-Hojjati S, Sattari M, Ghasemi T et al. Effect of platelet-rich plasma concentrations on the proliferation of periodontal cells: an in vitro study. Eur. J. Dent. 10(4), 469–474 (2016).
  MedlineGoogle Scholar
• 51. Mooren RE, Hendriks EJ, van den Beucken JJ et al. The effect of platelet-rich plasma in vitro on primary cells: rat osteoblast-like cells and human endothelial cells. Tissue Eng. Part A. 16(10), 3159–3172 (2010).
  Medline CASGoogle Scholar
• 52. Graziani F, Ivanovski S, Cei S et al. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin. Oral. Implants Res. 17(2), 212–219 (2006).
  MedlineGoogle Scholar
• 53. Veillette CJ, McKee MD. Growth factors–BMPs, DBMs, and buffy coat products: are there any proven differences amongst them? Injury. 38(S1), S38–S48 (2007).
  MedlineGoogle Scholar
• 54. Chen JC, Ko CL, Shih CJ et al. Calcium phosphate bone cement with 10 wt% platelet-rich plasma in vitro and in vivo. J. Dent. 40(2), 114–122 (2012).
  MedlineGoogle Scholar
• 55. Man Y, Wang P, Guo Y et al. Angiogenic and osteogenic potential of platelet-rich plasma and adipose-derived stem cell laden alginate microspheres. Biomaterials 33(34), 8802–8811 (2012).
  Medline CASGoogle Scholar
• 56. Yoshimi R, Yamada Y, Ito K et al. Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering. J. Craniofac. Surg. 20(5), 1523–1530 (2009).
  MedlineGoogle Scholar
• 57. Mooren RE, Merkx MA, Bronkhorst EM et al. The effect of platelet-rich plasma on early and late bone healing: an experimental study in goats. Int. J. Oral Maxillofac. Surg. 36(7), 626–631 (2007).
  Medline CASGoogle Scholar
• 58. Mooren RE, Dankers AC, Merkx MA et al. The effect of platelet-rich plasma on early and late bone healing using a mixture of particulate autogenous cancellous bone and Bio-Oss: an experimental study in goats. Int. J. Oral Maxillofac. Surg. 39(4), 371–378 (2010).
  Medline CASGoogle Scholar
• 59. Liu Z, Yuan X, Fernandes G et al. The combination of nano-calcium sulfate/platelet rich plasma gel scaffold with BMP2 gene-modified mesenchymal stem cells promotes bone regeneration in rat critical-sized calvarial defects. Stem Cell Res. Ther. 8(1), 122 (2017).
  MedlineGoogle Scholar
• 60. Fernandes G, Yang S. Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering. Bone Res. 4, 16036 (2016).
  Medline CASGoogle Scholar
• 61. Fernandes G, Wang C, Yuan X et al. Combination of controlled release platelet-rich plasma alginate beads and bone morphogenetic protein-2 genetically modified mesenchymal stem cells for bone regeneration. J. Periodontol. 87(4), 470–480 (2016).
  Medline CASGoogle Scholar
• 62. Yamada Y, Nakamura S, Ito K et al. Injectable tissue-engineered bone using autogenous bone marrow-derived stromal cells for maxillary sinus augmentation: clinical application report from a 2-6-year follow-up. Tissue Eng. Part A. 14(10), 1699–1707 (2008).
  Medline CASGoogle Scholar
• 63. Habraken WJ, Liao HB, Zhang Z et al. In vivo degradation of calcium phosphate cement incorporated into biodegradable microspheres. Acta. Biomater. 6(6), 2200–2211 (2010).
  Medline CASGoogle Scholar
• 64. Nauth A, Schemitsch E, Norris B et al. Critical-size bone defects: is there a consensus for diagnosis and treatment? J. Orthop. Trauma 32(S1), S7–S11 (2018).
  MedlineGoogle Scholar
• 65. Toogood P, Miclau T. Critical-sized bone defects: sequence and planning. J. Orthop. Trauma 31(S5), S23–S26 (2017).
  MedlineGoogle Scholar